...
首页> 外文期刊>Research journal of pharmacy and technology >Development and Evaluation of Controlled Porosity Osmotic Pump Tablets for Zidovudine and Lamivudine Combination
【24h】

Development and Evaluation of Controlled Porosity Osmotic Pump Tablets for Zidovudine and Lamivudine Combination

机译:对抗透射孔隙渗透泵片的开发与评价,用于齐凡押,拉米夫定组合

获取原文
获取原文并翻译 | 示例
           

摘要

The present work was aimed to develop and evaluate controlled porosity osmotic pump (CPOP) tablets of zidovudine-lamivudine combination for the treatment of AIDS. The tablets were prepared by wet granutation method incorporating drug, various excipients, controlled release polymer hydroxyl propyl methyl cellulose (HPMCE5M LV) and osmogen (Mannitol) in the core. The CPOP tablets consist of an osmotic core coated with a micro porous membrane made up of cellulose acetate (CA) which is incorporated with sorbitol as porogen. Prior to compression the prepared granules were evaluated for pre compression parameters such as angle of repose, bulk density, tapped density, Carr's index and Hausner's ratio. After compression the prepared granules were evaluated for thickness, coat thickness, hardness, weight variation, friability, drug content, diameter, in vitro drug release study and scanning electron microscopy (SEM) study. The release kinetics for different formulations were analyzed using zero order model equation, first order model equation, Higuchi model equation, Korsmeyer Peppas model equation and Hixson-Crowell equation. The optimized formulation of drug release was independent of pH, agitation intensity, but dependent on the osmotic pressure of the release media. FTIR and DSC study revealed that there was no interaction between drug and excipients. Formulations subjected to stability testing (at 40±2°C/75±5% RH) as per ICH guidelines for three months indicated stability with no significant changes in thickness, hardness, weight variation, friability, drug content and dissolution profiles.
机译:本作本作的旨在开发和评估Zidovudine-Lamivudine组合的控制孔隙渗透泵(CPOP)片剂,用于治疗艾滋病。通过掺入药物,各种赋形剂,控释聚合物羟基丙基甲基纤维素(HPMCE5M LV)和锇(甘露醇)的循环中的湿砂颗粒方法制备。 CPOP片剂由涂有由醋酸纤维素(CA)组成的微多孔膜的渗透芯组成,所述醋酸纤维素(CA)掺入山梨糖醇作为孔胶。在压制之前,评估制备的颗粒,用于预压缩参数,例如休息的角度,堆积密度,触发密度,Carr的指数和Hausner的比率。在压制后,评估制备的颗粒厚度,涂层厚度,硬度,重量变异,脆性,药物含量,直径,体外药物释放研究和扫描电子显微镜(SEM)研究。使用零级模型方程,第一阶模型方程,HIGUCHI模型方程,Korsmeyer Peppas模型方程和Hixson-Crowell方程分析了不同配方的释放动力学。药物释放的优化配方与pH,搅拌强度无关,但取决于释放介质的渗透压。 FTIR和DSC研究表明,药物和赋形剂之间没有相互作用。根据ICH指南进行稳定性测试的制剂(以40±2°C / 75±5%RH)为3个月,表明稳定性无明显变化,厚度,硬度,体重变化,脆性,药物含量和溶出谱。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号